April 22, 2016
The makers of COLD-FX might be feeling a little under the weather after appearing in the BC Superior Court to further respond to allegations that untrue representations and omissions induced consumers to purchase the drug product that was ineffective at providing “immediate relief” and therefore “worthless” if taken in accordance with the representations. The case…
Read More
April 8, 2016
It is the eighth year since the Chinese Anti-Monopoly Law (“AML”) came into effect. As the focus of the AML enforcement expands increasingly across a variety of industries these years, pharmaceutical sector becomes one of them. What is more, in 2015, some major Chinese legislation regarding pharmaceutical sector were revised to reduce the restrictions imposed…
Read More
March 22, 2016
Introduction In conformity with the Health Decree N° 3 (the Decree) that contains the Chilean Sanitary Regulation, pharmaceutical products can be marketed in Chile only upon securing a sanitary registration with the Regulatory Agency, the Chilean Health Institute (ISP). This Regulation establishes three different procedures for the registration of pharmaceutical products. First, an ordinary procedure…
Read More
January 15, 2016
Complex Regional Pain Syndrome (CRPS) often rears its ugly head in personal injury cases and can cause issues for lawyers acting on such cases due to the fact that is an injury frequently misunderstood and can be difficult to quantify. What is CRPS? CRPS is a condition which is not easily identified and is also…
Read More
November 19, 2015
The Smoke and Carbon Monoxide Alarm (England) Regulations 2015 came into force in the UK on 1st October 2015 with very little publicity. The regulations introduce new safety standards in all privately rented properties when it comes to preventing death by carbon monoxide poisoning from solid fuel appliances as well as preventing fires breaking out.…
Read More
